Medical Condition News

RSS

Inhaled nanoparticles can help treat lung cancer

Scientists have reported a new approach to treating lung cancer with inhaled nanoparticles developed at Wake Forest School of Medicine, part of Wake Forest Baptist Health.

14 Nov 2019

Earliest stage of hearing loss is linked to cognitive decline

Research has shown that adults with age-related hearing loss have higher rates of cognitive decline. Now, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found that even the earliest stage of hearing loss-when hearing is still considered normal - is linked to cognitive decline.

14 Nov 2019

Understanding how pressure is regulated in the eye could lead to new treatments for glaucoma

Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye.

14 Nov 2019

Short-term increases in sugar consumption could raise risk of inflammatory bowel disease

Short-term increases in sugar consumption could increase the risk of inflammatory bowel disease and have a significant impact on our health, a new study out of the University of Alberta suggests.

14 Nov 2019

Dopamine D2 receptor modulates Wnt expression, controls cell proliferation

The dopamine D2 receptor has a previously unobserved role in modulating Wnt expression and control of cell proliferation, according to a new study from the George Washington University and the University of Pittsburgh.

14 Nov 2019

New insights into how immune system and inflammation play a role in PD

Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.

14 Nov 2019

Study on sea sponge opens up possibilities to create new antitumor drugs

Chemists from Far Eastern Federal University's School of Natural Sciences developed a new method to synthesize biologically active derivatives of fascaplysin -- cytotoxic pigment of a sea sponge. For the first time, they got a sufficient amount of 3-bromofascaplysin and 3,10-dibromofascaplysin, which were known before but were not available for study.

14 Nov 2019

Using digital data and AI to improve quality of life for people with diabetes

Until now, medical doctors have used biomarkers to determine the health status of people with diabetes (PWDs).

14 Nov 2019

Alzheimer's Association's funding enables expansion of aging study in longest running birth cohort

The Alzheimer's Association and University College London are partnering to study brain aging and dementia in 500 individuals whose health and health-related behaviors have been documented since birth.

14 Nov 2019

New computational model could help in the development of anti-cancer drugs

Researchers from the Faculty of Medicine and the Institute for Molecular Medicine at the University of Helsinki have developed a computational model, Combined Essentiality Scoring (CES) that enables accurate identification of essential genes in cancer cells for development of anti-cancer drugs.

14 Nov 2019

Study sheds light on how HIV infection may increase risk for sudden cardiac death

The success of antiretroviral therapies has extended the lives of people living with HIV, long enough for other chronic health conditions to emerge, including a recently documented uptick in sudden death.

14 Nov 2019

Good fitness linked to longer life without dementia

It is important to say that it is never too late to begin exercising. The average participant in our study was around 60 years old at baseline, and improvement in cardiorespiratory fitness was strongly linked to lower dementia risk.

14 Nov 2019

Blocking a molecule could delay the progression of multiple sclerosis

Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown. Presently, they have no hope for a cure.

14 Nov 2019

Study finds sex differences in treatment and outcome after stroke

Women are more likely to survive a stroke, but have worse disability and poorer quality of life afterwards compared to men, according to research published in the latest issue of Neurology, the medical journal of the American Academy of Neurology.

14 Nov 2019

Blocking metastasis-promoting enzyme can prevent spread of breast cancer

In a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.

14 Nov 2019

Knocking out 'survival system' of cancer cells could improve effectiveness of melanoma treatment

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the 'survival system' of cancer cells according to a study published in Nature Communications today.

14 Nov 2019

Simple 'nudges' help improve heart patients' adherence to statins

Statins are an effective medication for treating patients with heart disease - they cut the risk of a second major adverse cardiac event by almost 50 percent. But only about six percent of patients take statins as prescribed. One way to solve that? Nudge them. Literally.

14 Nov 2019

Alzheimer's Research UK urges all political parties to invest in dementia research

Alzheimer's Research UK is calling on all political parties to drive forward efforts to find life-changing treatments for dementia – by urging them to commit just 1% of the annual cost of dementia on research in this general election.

14 Nov 2019

Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank

Fight for Sight is funding a project to create the UK’s first large-scale glaucoma biobank, a new tool that will help personalize glaucoma treatment and identify patients most at risk of sight loss.

14 Nov 2019

Study examines efficacy of nutraceuticals to manage diabetes

Every five minutes, someone in Australia is diagnosed with diabetes. It’s Australia’s fastest growing chronic condition, but as its prevalence grows more people are adding dietary supplements to their diets in the hope of reducing their risk of the disease.

14 Nov 2019

Medical Condition News

Inhaled nanoparticles can help treat lung cancer

Earliest stage of hearing loss is linked to cognitive decline

Understanding how pressure is regulated in the eye could lead to new treatments for glaucoma

Short-term increases in sugar consumption could raise risk of inflammatory bowel disease

Dopamine D2 receptor modulates Wnt expression, controls cell proliferation

New insights into how immune system and inflammation play a role in PD

Study on sea sponge opens up possibilities to create new antitumor drugs

Using digital data and AI to improve quality of life for people with diabetes

Alzheimer's Association's funding enables expansion of aging study in longest running birth cohort

New computational model could help in the development of anti-cancer drugs

Study sheds light on how HIV infection may increase risk for sudden cardiac death

Good fitness linked to longer life without dementia

Blocking a molecule could delay the progression of multiple sclerosis

Study finds sex differences in treatment and outcome after stroke

Blocking metastasis-promoting enzyme can prevent spread of breast cancer

Knocking out 'survival system' of cancer cells could improve effectiveness of melanoma treatment

Simple 'nudges' help improve heart patients' adherence to statins

Alzheimer's Research UK urges all political parties to invest in dementia research

Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank

Study examines efficacy of nutraceuticals to manage diabetes

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News